Laennec Placentex Integro Placenta Placentex Meso Pdrn Placentex Anti-Aging Skin Tightening

• Customization: Available
• Certification: ISO, CE
• Disinfection: Disinfection
• Model NO.: Japan Laennec
• Color: Transparent
• Application: Face
• Name: Laennec
• MOQ: 1
• Expiration Date: 2 Years
• Effect: Detoxification Protects The Liver
• Transport Package: Box
• Specification: 50*2ml
• Trademark: Laennec
• Origin: Japan
• Production Capacity: 5000

Product Description

Laennec Placentex Integro Placenta Placentex Meso Pdrn Placentex Anti-Aging Skin Tightening
 

Product Introduction

Laennec is the ethical drug manufactured with JBP's unique technologies for effective extraction of variety , cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte ) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standards.

COMPOSITION
Each 2 mL ampoule of this product contains 112 mg of a water-soluble human placenta hydrolysis by extracting.
Content per 2 mL
 

	Component	Content	Remarks
Active ingredient	Water-soluble human placenta hydrolysis by extracting	112 mg	Component derived from human placenta
Inactive ingredients	pH adjuster	Sufficient quantity	_

PRODUCT DESCRIPTION
This product is a light yellow-brown or yellow-brown transparent liquid with a distinctive odor. The pH level ranges from 5.5 to 6.5 and the osmotic pressure ratio (to physiological saline) is approximately one.

 

INDICATION(S)
Improvement of hepatic function in chronic hepatic disease.

 

DOSAGE AND ADMINISTRATION
A normal adult dose is a 2 ml subcutaneous or intramuscular injection once daily. According to symptoms, the dose can be increased to 2 or 3 times daily.

 

7. Precautions concerning Use
Injection site:
In order to avoid any effect on tissue or nerves, this product should be injected subcutaneously or intramuscularly taking the following precautions:
  a) Care should be taken when administering to avoid nerve pathways at the injection site.
  b) In the case of repeated injections, avoid injecting into the same site by alternating left and right sides etc.
  c) On insertion of the needle, if the patient complains of intense pain or if blood backflow is observed, the needle should be removed immediately, and injected into a different site.